From Wikipedia, the free encyclopedia
Jump to: navigation, search
V-akt murine thymoma viral oncogene homolog 2
Protein AKT2 PDB 1gzk.png
PDB rendering based on 1gzk.
Available structures
PDB Ortholog search: PDBe, RCSB
External IDs OMIM164731 MGI104874 HomoloGene48773 ChEMBL: 2431 GeneCards: AKT2 Gene
EC number
RNA expression pattern
PBB GE AKT2 203809 s at tn.png
PBB GE AKT2 211453 s at tn.png
More reference expression data
Species Human Mouse
Entrez 208 11652
Ensembl ENSG00000105221 ENSMUSG00000004056
UniProt P31751 Q60823
RefSeq (mRNA) NM_001243027 NM_001110208
RefSeq (protein) NP_001229956 NP_001103678
Location (UCSC) Chr 19:
40.74 – 40.79 Mb
Chr 7:
27.59 – 27.64 Mb
PubMed search [1] [2]

RAC-beta serine/threonine-protein kinase is an enzyme that in humans is encoded by the AKT2 gene.[1]

This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. The gene was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. Overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phosphorylating several known proteins.[2] Mice lacking Akt2 have a normal body mass, but display a profound diabetic phenotype, indicating that Akt2 plays a key role in signal transduction downstream of the insulin receptor. Mice lacking Akt2 show worse outcome in breast cancer initaited by the large T antigen as well as the neu oncogene.


AKT2 has been shown to interact with TCL1A,[3][4] APPL1,[5] SH3RF1[6] and CHUK.[7]


  1. ^ Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN, Testa JR (November 1992). "AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas". Proc Natl Acad Sci U S A 89 (19): 9267–71. doi:10.1073/pnas.89.19.9267. PMC 50107. PMID 1409633. 
  2. ^ "Entrez Gene: AKT2 v-akt murine thymoma viral oncogene homolog 2". 
  3. ^ Laine, Jarmo; Künstle Gerald; Obata Toshiyuki; Noguchi Masayuki (February 2002). "Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family". J. Biol. Chem. (United States) 277 (5): 3743–51. doi:10.1074/jbc.M107069200. ISSN 0021-9258. PMID 11707444. 
  4. ^ Laine, J; Künstle G; Obata T; Sha M; Noguchi M (August 2000). "The protooncogene TCL1 is an Akt kinase coactivator". Mol. Cell (UNITED STATES) 6 (2): 395–407. doi:10.1016/S1097-2765(00)00039-3. ISSN 1097-2765. PMID 10983986. 
  5. ^ Mitsuuchi, Y; Johnson S W; Sonoda G; Tanno S; Golemis E A; Testa J R (September 1999). "Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2". Oncogene (ENGLAND) 18 (35): 4891–8. doi:10.1038/sj.onc.1203080. ISSN 0950-9232. PMID 10490823. 
  6. ^ Figueroa, Claudia; Tarras Samantha; Taylor Jennifer; Vojtek Anne B (November 2003). "Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex". J. Biol. Chem. (United States) 278 (48): 47922–7. doi:10.1074/jbc.M307357200. ISSN 0021-9258. PMID 14504284. 
  7. ^ Yuan, Zeng-qiang; Feldman Richard I; Sun Mei; Olashaw Nancy E; Coppola Domenico; Sussman Gene E; Shelley Sue A; Nicosia Santo V; Cheng Jin Q (August 2002). "Inhibition of JNK by cellular stress- and tumor necrosis factor alpha-induced AKT2 through activation of the NF kappa B pathway in human epithelial Cells". J. Biol. Chem. (United States) 277 (33): 29973–82. doi:10.1074/jbc.M203636200. ISSN 0021-9258. PMID 12048203. 

Further reading[edit]